Medical University of Vienna-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2020

  1. Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer-action of FASN-inhibitors: a multi-omics analysis in ovarian cancer

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

    Oncotarget, Vol. 8, Núm. 7, pp. 11600-11613

2015

  1. Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

    International Journal of Cancer, Vol. 136, Núm. 9, pp. 2078-2090

2014

  1. The expression of cannabinoid receptor 1 is significantly increased in atopic patients

    Journal of Allergy and Clinical Immunology, Vol. 133, Núm. 3